Clinical Ink

About Clinical Ink

Clinical Ink operates in the healthcare technology sector, specializing in providing advanced eSource solutions for clinical trials. The company serves pharmaceutical companies, contract research organizations (CROs), and academic institutions. Clinical Ink's core offerings include Direct Data Capture (DDC), electronic Clinical Outcome Assessments (eCOA), electronic Patient-Reported Outcomes (ePRO), and electronic Consent (eConsent). These tools are designed to streamline the clinical trial process, making it more efficient and patient-centric. The business model is primarily subscription-based, with clients paying for access to their suite of digital tools and services. Revenue is generated through these subscriptions, as well as through additional services such as rapid build timelines and virtual trial support. Clinical Ink's market is global, with a focus on improving the quality and efficiency of clinical trials through innovative technology solutions.